Jean-Paul Clozel – CEO & Co-Founder, Actelion,…
Actelion’s global CEO and co-founder, Dr. Jean-Paul Clozel, discusses diversifying the company’s portfolio, prioritizing internal research over…
Interview: André Lüscher – General Manager, Gilead…
André Lüscher of Gilead Switzerland, reveals how the case of Sovaldi demonstrates the challenges for a healthcare system to handle a truly…
Interview: Andreas Bosshard – General Manager, Mepha-Teva,…
Andreas Bosshard of Mepha-Teva in Switzerland describes Switzerland’s unique generics market, the quality of the Mepha-Teva brand, innovations…
Interview: Franz A. Saladin – Director, Basel Chamber of…
Franz Saladin details the unique scope and operations of the Basel Chamber of Commerce, the history of pharmaceuticals in Basel, and the importance of…
Interview: Natascha Schill – Managing Director, Biogen…
MD Natascha Schill discusses the growing importance and commitment that Biogen has to Switzerland, including a USD one billion investment in new…
Interview: Pascal Strupler – Director General, Federal…
Pascal Strupler of the Federal Office of Public Health discusses the intricacies of the Swiss healthcare system, highlighting the importance of the…
Interview: Olaf Weppner – General Manager, AbbVie…
Olaf Weppner, General Manager of AbbVie Switzerland, highlights AbbVie’s intended foray into oncology, the importance of immunology to the group,…
Interview: Dr. Catherine Chammartin – Director General,…
Dr. Catherine Chammartin of the Swiss Federal Institute of Intellectual Property (IPI) describes the strong elements of an IP system and its…
Interview: Tuomo Pätsi – President EMEA, Celgene,…
Tuomo Pätsi, President of the EMEA region for Celgene, talks about marking the tenth anniversary of Switzerland as Celgene´s EMEA headquarters;…
Interview: Prof. Dr. med. Adriano Aguzzi – Director,…
Prof. Dr. med. Adriano Aguzzi provides insight on the past, present, and future of prion and antibody therapy research in Switzerland. The Institute…
Interview: Prof. Jürg Utzinger – Director, Swiss Tropical…
Professor Jürg Utzinger of the Swiss Tropical and Public Health Institute (Swiss TPH) emphasizes the importance of partnerships and sharing…
Interview: Daniel Breitenstein – Vice President &…
Daniel Breitenstein, VP and GM of GSK Switzerland, discusses the benefits of GSK’s three-part transaction with Novartis; the importance of…